[AAES, T.A.A.o.E.S. Primary hyperaldosteronism (Conn’s syndrome or aldosterone-producing adrenal tumor). Patient Education. 2016.]Search in Google Scholar
[Agharazii M, Douville P, Grose JH, Lebel M. Captopril suppression versus salt loading in confirming primary aldosteronism. Hypertension 37, 1440-1443, 2001.10.1161/01.HYP.37.6.144011408392]Search in Google Scholar
[Ahmed AH, Gordon RD, Sukor N, Pimenta E, Stowasser M. Quality of life in patients with bilateral primary aldosteronism before and during treatment with spironolactone and/or amiloride, including a comparison with our previously published results in those with unilateral disease treated surgically. J Clin Endocrinol Metab 96, 2904-2911, 2011.10.1210/jc.2011-013821778218]Open DOISearch in Google Scholar
[Al-Salameh A, Cohen R, Desailloud R. Overview of the genetic determinants of primary aldosteronism. Appl Clin Genet 7, 67-79, 2014.10.2147/TACG.S45620401234524817817]Open DOISearch in Google Scholar
[Amar L, Lorthioir A, Azizi M, Plouin PF. Progress in primary aldosteronism. Mineralocorticoid antagonist treatment for aldosterone-producing adenoma. Eur J Endocrinol 172, R125-R129, 2015.10.1530/EJE-14-058525315875]Search in Google Scholar
[Armanini D, Karbowiak I, Goi A, Mantero F, Funder JW. In-vivo metabolites of spironolactone and potassium canrenoate: determination of potential anti-androgenic activity by a mouse kidney cytosol receptor assay. Clin Endocrinol (Oxf) 23, 341-347, 1985.10.1111/j.1365-2265.1985.tb01090.x4064345]Open DOISearch in Google Scholar
[Aronova A, Fahey TJ, Zarnegar R Management of hypertension in primary aldosteronism. World J Cardiol 6, 227-233, 2014a.10.4330/wjc.v6.i5.227406212524944753]Open DOISearch in Google Scholar
[Aronova A, Gordon BL, Finnerty BM, Zarnegar R, Fahey TJ 3rd. Aldosteronoma resolution score predicts long-term resolution of hypertension. Surgery 156, 1387-1393, 2014b.10.1016/j.surg.2014.08.01925456916]Search in Google Scholar
[Assalia A, Gagner M. Laparoscopic adrenalectomy. Br J Surg 91, 1259-1274, 2004.10.1002/bjs.473815376201]Search in Google Scholar
[Bagrodia A, Kopp RP, Mehrazin R, Lee HJ, Liss MA, Jabaji R, Kane CJ, Wake RW, Patterson AL, Wan JY, Derweesh IH. Impact of renal surgery for cortical neoplasms on lipid metabolism. BJU Int 114, 837-843, 2014.10.1111/bju.1274424656182]Search in Google Scholar
[Bergstrom M, Juhlin C, Bonasera TA, Sundin A, Rastad J, Akerstrom G, Langstrom B. PET imaging of adrenal cortical tumors with the 11beta-hydroxylase tracer 11C-metomidate. J Nucl Med 41, 275-282, 2000.]Search in Google Scholar
[Boland GW, Dwamena BA, Jagtiani Sangwaiya M, Goehler AG, Blake MA, Hahn PF, Scott JA, Kalra MK. Characterization of adrenal masses by using FDG PET: a systematic review and meta-analysis of diagnostic test performance. Radiology 259, 117-126, 2011.10.1148/radiol.1110056921330566]Search in Google Scholar
[Brown NJ. Aldosterone and end-organ damage. Curr Opin Nephrol Hypertens 14, 235-241, 2005.10.1097/01.mnh.0000165889.60254.9815821416]Search in Google Scholar
[Brown MJ. Primary Aldosteronism: the spectre of cure. Clin Endocrinol (Oxf) 82, 785-788, 2015.10.1111/cen.1279625891888]Search in Google Scholar
[Brunt LM. Minimal access adrenal surgery. Surg Endosc 20, 351-361, 2006.10.1007/s00464-004-8269-316437282]Open DOISearch in Google Scholar
[Brunt LM, Moley JF. Adrenal incidentaloma. World J Surg 25, 905-913, 2001.10.1007/s00268-001-0029-011572032]Open DOISearch in Google Scholar
[Burton TJ, Mackenzie IS, Balan K, Koo B, Bird N, Soloviev DV, Azizan EA, Aigbirhio F, Gurnell M, Brown MJ. Evaluation of the sensitivity and specificity of 11C-metomidate positron emission tomography (PET)-CT for lateralizing aldosterone secretion by Conn’s adenomas. J Clin Endocrinol Metab 97, 100-109, 2012.10.1210/jc.2011-153722112805]Search in Google Scholar
[Chai YJ, Kwon H, Yu HW, Kim SJ, Choi JY, Lee KE, Youn YK. Systematic review of surgical approaches for adrenal tumors: lateral transperitoneal versus posterior retroperitoneal and laparoscopic versus robotic adrenalectomy. Int J Endocrinol 2014, 918346, 2014.10.1155/2014/918346428139825587275]Search in Google Scholar
[Chao CT, Wu VC, Kuo CC, Lin YH, Chang CC, Chueh SJ, Wu KD, Pimenta E, Stowasser M. Diagnosis and management of primary aldosteronism: an updated review. Ann Med 45, 375-383, 2013.10.3109/07853890.2013.78523423701121]Open DOISearch in Google Scholar
[Chen W, Li F, Chen D, Zhu Y, He C, Du Y, Tan W. Retroperitoneal versus transperitoneal laparoscopic adrenalectomy in adrenal tumor: a meta-analysis. Surg Laparosc Endosc Percutan Tech 23, 121-127, 2013.10.1097/SLE.0b013e3182827b5723579504]Open DOISearch in Google Scholar
[Chiang WF, Cheng CJ, Wu ST, Sun GH, Lin MY, Sung CC, Lin SH. Incidence and factors of post-adrenalectomy hyperkalemia in patients with aldosterone producing adenoma. Clin Chim Acta 424, 114-118, 2013.10.1016/j.cca.2013.05.01723727469]Search in Google Scholar
[Conder G, Rendle J, Kidd S, Misra RR. A-Z of Abdominal Radiology, Cambridge University Press, Cambridge, UK, 28-37, 2009.10.1017/CBO9780511575792]Search in Google Scholar
[Conn JW. Presidential address. I. Painting background. II. Primary aldosteronism, a new clinical syndrome. J Lab Clin Med 45, 3-17, 1955.]Search in Google Scholar
[Constantinides VA, Christakis I, Touska P, Palazzo FF. Systematic review and meta-analysis of retroperitoneoscopic versus laparoscopic adrenalectomy. Br J Surg 99, 1639-1648, 2012.10.1002/bjs.8921]Search in Google Scholar
[Ctvrtlik F, Koranda P, Tichy T. Adrenal disease: a clinical update and overview of imaging. A review. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 158, 23-34, 2014.10.5507/bp.2014.010]Search in Google Scholar
[Dunnick NR, Korobkin M. Imaging of adrenal incidentalomas: current status. AJR Am J Roentgenol 179, 559-568, 2002.10.2214/ajr.179.3.1790559]Search in Google Scholar
[Dupont A. Disappearance of spironolactone-induced gynaecomastia during treatment with potassium canrenoate. Lancet 2, 731, 1985.10.1016/S0140-6736(85)92975-7]Open DOISearch in Google Scholar
[Fardella CE, Mosso L, Gomez-Sanchez C, Cortes P, Soto J, Gomez L, Pinto M, Huete A, Oestreicher E, Foradori A, Montero J. Primary hyperaldosteronism in essential hypertensives: prevalence, biochemical profile, and molecular biology. J Clin Endocrinol Metab 85 1863-1867, 2000.10.1210/jcem.85.5.659610843166]Search in Google Scholar
[Fischer E, Hanslik G, Pallauf A, Degenhart C, Linsenmaier U, Beuschlein F, Bidlingmaier M, Mussack T, Ladurner R, Hallfeldt K, Quinkler M, Reincke M. Prolonged zona glomerulosa insufficiency causing hyperkalemia in primary aldosteronism after adrenalectomy. J Clin Endocrinol Metab 97, 3965-3973, 2012.10.1210/jc.2012-223422893716]Open DOISearch in Google Scholar
[Fischer E, Reuschl S, Quinkler M, Rump LC, Hahner S, Bidlingmaier M, Reincke M; Participants of the German Conn’s Registry-Else Kroner-Fresenius-Hyperaldosteronism Registry. Assay characteristics influence the aldosterone to renin ratio as a screening tool for primary aldosteronism: results of the German Conn’s registry. Horm Metab Res 45, 526-531, 2013.10.1055/s-0033-134344823613013]Search in Google Scholar
[Fleming T, ed. 2005 Red Book: Pharmacy’s Fundamental Reference. Montvale NJ: Thomson PDR, 2005.]Search in Google Scholar
[Funder JW, Carey RM, Fardella C, Gomez-Sanchez CE, Mantero F, Stowasser M, Young WF Jr, Montori VM; Endocrine Society. Case detection, diagnosis, and treatment of patients with primary aldosteronism: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 93, 3266-3281, 2008.10.1210/jc.2008-010418552288]Open DOISearch in Google Scholar
[Geller DS, Zhang J, Wisgerhof MV, Shackleton C, Kashgarian M, Lifton RP. A novel form of human mendelian hypertension featuring nonglucocorticoid-remediable aldosteronism. J Clin Endocrinol Metab 93, 3117-3123, 2008.10.1210/jc.2008-0594251508318505761]Open DOISearch in Google Scholar
[Giacchetti G, Ronconi V, Lucarelli G, Boscaro M, Mantero F. Analysis of screening and confirmatory tests in the diagnosis of primary aldosteronism: need for a standardized protocol. J Hypertens 24, 737-745, 2006.10.1097/01.hjh.0000217857.20241.0f16531803]Open DOISearch in Google Scholar
[Gordon R. Mineralocorticoid hypertension. Lancet 344, 240-243, 1994.10.1016/S0140-6736(94)93003-1]Search in Google Scholar
[Gordon RD, Stowasser M, TunnyTJ, Klemm SA, Rutherford JC. High incidence of primary aldosteronism in 199 patients referred with hypertension. Clin Exp Pharmacol Physiol 21, 315-318, 1994.10.1111/j.1440-1681.1994.tb02519.x]Open DOISearch in Google Scholar
[Gordon R. Primary aldosteronism. J Endocrinol Invest 18, 495-511, 1995.10.1007/BF03349761]Open DOISearch in Google Scholar
[Gordon RD. Diagnostic investigations in primary aldosteronism. In: Zanchetti A (ed.), Clinical Medicine Series on Hypertension. Maidenhead: McGraw-Hill International (UK) Ltd; pp. 101-114, 2001.]Search in Google Scholar
[Hiramatsu K, Yamada T, Yukimura Y, Komiya I, Ichikawa K, Ishihara M, Nagata H, Izumiyama T. A screening test to identify aldosterone-producing adenoma by measuring plasma renin activity: results in hypertensive patients. Arch Intern Med 141, 1589-1593, 1981.10.1001/archinte.141.12.1589]Search in Google Scholar
[Hofer M. Kidneys and Adrenal Glands. Ultrasound Teaching Manual Hofer, Matthias, Thieme, 37-50, 1999.]Search in Google Scholar
[Hood S, Cannon J, Foo R, Brown M. Prevalence of primary hyperaldosteronism assessed by aldosterone/renin ratio and spironolactone testing. Clin Med (Lond) 5, 55-60, 2005.10.7861/clinmedicine.5-1-55]Search in Google Scholar
[Iacobone M, Citton M, Viel G, Rossi GP, Nitti D. Approach to the surgical management of primary aldosteronism. Gland Surg 4, 69-81, 2015.]Search in Google Scholar
[Ilias I, Sahdev A, Reznek RH, Grossman AB, Pacak K. The optimal imaging of adrenal tumours: a comparison of different methods. Endocr Relat Cancer 14, 587-599, 2007.10.1677/ERC-07-0045]Open DOISearch in Google Scholar
[Jeunemaitre X, Chatellier G, Kreft-Jais C, Charru A, DeVries C, Plouin PF, Corvol P, Menard J. Efficacy and tolerance of spironolactone in essential hypertension. Am J Cardiol 60, 820-825, 1987.10.1016/0002-9149(87)91030-7]Open DOISearch in Google Scholar
[Kaga M, Utsumi T, Tanaka T, Kono T, Nagano H, Kawamura K, Kamiya N, Imamoto T, Nihei N, Naya Y, Suzuki H, Ichikawa T. Risk of new-onset dyslipidemia after laparoscopic adrenalectomy in patients with primary aldosteronism. World J Surg 39, 2935-2940, 2015.10.1007/s00268-015-3197-z26296835]Search in Google Scholar
[Kahn SL, Angle JF. Adrenal vein sampling. Tech Vasc Interv Radiol 13, 110-125, 2010.10.1053/j.tvir.2010.02.00620540920]Search in Google Scholar
[Kem DC, Weinberger MH, Mayes DM, Nugent CA. Saline suppression of plasma aldosterone in hypertension. Arch Intern Med 128, 380-386, 1971.10.1001/archinte.128.3.380]Search in Google Scholar
[Kline GA. Primary Aldosteronism: unnecessary complexity in definition and diagnosis as a barrier to wider clinical care. Clin Endocrinol (Oxf) 82, 779-784, 2015.10.1111/cen.1279825891981]Search in Google Scholar
[Kucharz EJ. [Michal Litynski--a forgotten author of the first description on primary hyperaldosteronism]. Pol Arch Med Wewn 117, 57-58, 2007.10.20452/pamw.79]Search in Google Scholar
[Lafferty AR, Torpy DJ, Stowasser M, Taymans SE, Lin JP, Huggard P, Gordon RD, Stratakis CA. A novel genetic locus for low renin hypertension: familial hyperaldosteronism type II maps to chromosome 7 (7p22). J Med Genet 37, 831-835, 2000.10.1136/jmg.37.11.831173446811073536]Search in Google Scholar
[Lee J, El-Tamer M, Schifftner T, Turrentine FE, Henderson WG, Khuri S, Hanks JB, Inabnet WB 3rd. Open and laparoscopic adrenalectomy: analysis of the National Surgical Quality Improvement Program. J Am Coll Surg 206, 953-961, 2008.10.1016/j.jamcollsurg.2008.01.01818471733]Search in Google Scholar
[Letavernier E, Peyrard S, Amar L, Zinzindohoue F, Fiquet B, Plouin PF. Blood pressure outcome of adrenalectomy in patients with primary hyperaldosteronism with or without unilateral adenoma. J Hypertens 26, 1816-1823, 2008.10.1097/HJH.0b013e3283060f0c18698217]Open DOISearch in Google Scholar
[Litchfield WR, Anderson BF, Weiss RJ, Lifton RP, Dluhy RG. Intracranial aneurysm and hemorrhagic stroke in glucocorticoid-remediable aldosteronism. Hypertension 31, 445-450, 1998.10.1161/01.HYP.31.1.445]Open DOISearch in Google Scholar
[Mantero F, Fallo F, Opocher G, Armanini D, Boscaro M, Scaroni C. Effect of angiotensin II and converting enzyme inhibitor (captopril) on blood pressure, plasma renin activity and aldosterone in primary aldosteronism. Clin Sci (Lond) 61, 289s-293s, 1981.10.1042/cs061289s7032817]Open DOISearch in Google Scholar
[Mantero F, Terzolo M, Arnaldi G, Osella G, Masini AM, Ali A, Giovagnetti M, Opocher G, Angeli A. A survey on adrenal incidentaloma in Italy. Study Group on Adrenal Tumors of the Italian Society of Endocrinology. J Clin Endocrinol Metab 85, 637-644, 2000.10.1210/jcem.85.2.637210690869]Search in Google Scholar
[Mattsson C, Young WF. Primary aldosteronism: diagnostic and treatment strategies. Nat Clin Pract Nephrol 2, 198-208, 2006.10.1038/ncpneph015116932426]Open DOISearch in Google Scholar
[McCurley A, Pires PW, Bender SB, Aronovitz M, Zhao MJ, Metzger D, Chambon P, Hill MA, Dorrance AM, Mendelsohn ME, Jaffe IZ. Direct regulation of blood pressure by smooth muscle cell mineralocorticoid receptors. Nat Med 18, 1429-1433, 2012.10.1038/nm.2891349108522922412]Open DOISearch in Google Scholar
[McKenna TJ, Sequeira SJ, Heffernan A, Chambers J, Cunningham S. Diagnosis under random conditions of all disorders of the renin-angiotensin-aldosterone axis, including primary hyperaldosteronism. J Clin Endocrinol Metab 73, 952-957, 1991.10.1210/jcem-73-5-9521939533]Search in Google Scholar
[Melby JC, Spark RF, Dale SL, Egdahl RH, Kahn PC. Diagnosis and localization of aldosterone-producing adenomas by adrenal-vein catheterization. N Engl J Med 277, 1050-1056, 1967.10.1056/NEJM1967111627720026059584]Search in Google Scholar
[Mengozzi G, Rossato D, Bertello C, Garrone C, Milan A, Pagni R, Veglio F, Mulatero P. Rapid cortisol assay during adrenal vein sampling in patients with primary aldosteronism. Clin Chem 53, 1968-1971, 2007.10.1373/clinchem.2007.09208017901112]Search in Google Scholar
[Milliez P, Girerd X, Plouin PF, Blacher J, Safar ME, Mourad JJ. Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism. J Am Coll Cardiol 45, 1243-1248, 2005.10.1016/j.jacc.2005.01.01515837256]Open DOISearch in Google Scholar
[Monticone S, Hattangady NG, Penton D, Isales CM, Edwards MA, Williams TA, Sterner C, Warth R, Mulatero P, Rainey WE. A novel Y152C KCNJ5 mutation responsible for familial hyperaldosteronism type III. J Clin Endocrinol Metab 98, E1861-E1865, 2013.10.1210/jc.2013-2428381626524037882]Search in Google Scholar
[Moraitis A, Stratakis C. Adrenocortical causes of hypertension. Int J Hypertens 2011, 624691, 2011.10.4061/2011/624691305702921423682]Search in Google Scholar
[Mulatero P, Rabbia F, Milan A, Paglieri C, Morello F, Chiandussi L, Veglio F. Drug effects on aldosterone/plasma renin activity ratio in primary aldosteronism. Hypertension 40, 897-902, 2002.10.1161/01.HYP.0000038478.59760.4112468576]Open DOISearch in Google Scholar
[Mulatero P, Stowasser M, Loh KC, Fardella CE, Gordon RD, Mosso L, Gomez-Sanchez CE, Veglio F, Young WF Jr. Increased diagnosis of primary aldosteronism, including surgically correctable forms in centers from five continents. J Clin Endocrinol Metab 89, 1045-1050, 2004.10.1210/jc.2003-03133715001583]Search in Google Scholar
[Mulatero P, Monticone S, Bertello C, Viola A, Tizzani D, Iannaccone A, Crudo V, Burrello J, Milan A, Rabbia F, Veglio F. Long-term cardio- and cerebrovascular events in patients with primary aldosteronism. J Clin Endocrinol Metab 98, 4826-4833, 2013.10.1210/jc.2013-280524057288]Open DOISearch in Google Scholar
[Papierska L, Cichocki A, Sankowski AJ, Cwikla JB. Adrenal incidentaloma imaging - the first steps in therapeutic management. Pol J Radiol 78, 47-55, 2013.10.12659/PJR.889541390850724505223]Search in Google Scholar
[Piecha G, Adamczak M, Ritz E. Dyslipidemia in chronic kidney disease. Pol Arch Med Wewn 119, 487-492, 2009.10.20452/pamw.745]Search in Google Scholar
[Powlson AS, Gurnell M, Brown MJ. Nuclear imaging in the diagnosis of primary aldosteronism. Curr Opin Endocrinol Diabetes Obes 22, 150-156, 2015.10.1097/MED.0000000000000148]Search in Google Scholar
[Probst KA, Ohlmann CH, Saar M, Siemer S, Stoeckle M, Janssen M. Robot-assisted vs open adrenalectomy: evaluation of cost-effectiveness and peri-operative outcome. BJU Int 118, 952-957, 2016.10.1111/bju.13529]Open DOISearch in Google Scholar
[Ramsay LE, Hettiarachchi J, Fraser R, Morton JJ. Amiloride, spironolactone, and potassium chloride in thiazidetreated hypertensive patents. Clin Pharmacol Ther 27, 533-543, 1980.10.1038/clpt.1980.75]Open DOISearch in Google Scholar
[Reincke M, Rump LC, Quinkler M, Hahner S, Diederich S, Lorenz R, Seufert J, Schirpenbach C, Beuschlein F, Bidlingmaier M, Meisinger C, Holle R, Endres S; Participants of German Conn’s Registry. Risk factors associated with a low glomerular filtration rate in primary aldosteronism. J Clin Endocrinol Metab 94, 869-875, 2009.10.1210/jc.2008-1851]Open DOISearch in Google Scholar
[Rossi E, Regolisti G, Negro A, Sani C, Davoli S, Perazzoli F. High prevalence of primary aldosteronism using postcaptopril plasma aldosterone to renin ratio as a screening test among Italian hypertensives. Am J Hypertens 15, 896-902, 2002.10.1016/S0895-7061(02)02969-2]Open DOISearch in Google Scholar
[Rossi GP, Bernini G, Caliumi C, Desideri G, Fabris B, Ferri C, Ganzaroli C, Giacchetti G, Letizia C, Maccario M, Mallamaci F, Mannelli M, Mattarello MJ, Moretti A, Palumbo G, Parenti G, Porteri E, Semplicini A, Rizzoni D, Rossi E, Boscaro M, Pessina AC, Mantero F; PAPY Study Investigators. A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients. J Am Coll Cardiol 48, 2293-2300, 2006a.10.1016/j.jacc.2006.07.05917161262]Search in Google Scholar
[Rossi GP, Bernini G, Desideri G, Fabris B, Ferri C, Giacchetti G, Letizia C, Maccario M, Mannelli M, Matterello MJ, Montemurro D, Palumbo G, Rizzoni D, Rossi E, Pessina AC, Mantero F; PAPY Study Participants. Renal damage in primary aldosteronism results of the PAPY study. Hypertension 48, 232-238, 2006b.10.1161/01.HYP.0000230444.01215.6a16801482]Open DOISearch in Google Scholar
[Rossi GP, Ganzaroli C, Miotto D, De Toni R, Palumbo G, Feltrin GP, Mantero F, Pessina AC. Dynamic testing with high-dose adrenocorticotrophic hormone does not improve lateralization of aldosterone oversecretion in primary aldosteronism patients. J Hypertens 24, 371-379, 2006c.10.1097/01.hjh.0000202818.10459.9616508586]Open DOISearch in Google Scholar
[Rossi GP, Belfiore A, Bernini G, Desideri G, Fabris B, Ferri C, Giacchetti G, Letizia C, Maccario M, Mallamaci F, Mannelli M, Palumbo G, Rizzoni D, Rossi E, Agabiti-Rosei E, Pessina AC, Mantero F; Primary Aldosteronism Prevalence in Italy Study Investigators. Comparison of the captopril and the saline infusion test for excluding aldosterone-producing adenoma. Hypertension 50, 424-443, 2007.10.1161/HYPERTENSIONAHA.107.09182717592070]Open DOISearch in Google Scholar
[Rossi GP, Pitter G, Bernante P, Motta R, Feltrin G, Miotto D. Adrenal vein sampling for primary aldosteronism: the assessment of selectivity and lateralization of aldosterone excess baseline and after adrenocorticotropic hormone (ACTH) stimulation. J Hypertens 26, 989-997, 2008.10.1097/HJH.0b013e3282f9e66a18398342]Open DOISearch in Google Scholar
[Schirpenbach C, Seiler L, Maser-Gluth C, Rudiger F, Nickel C, Beuschlein F, Reincke M. Confirmatory testing in normokalaemic primary aldosteronism: the value of saline infusion test and urinary aldosterone metabolites. Eur J Endocrinol 154, 865-873, 2006.10.1530/eje.1.0216416728547]Search in Google Scholar
[Schirpenbach C, Reincke M. Primary aldosteronism: current knowledge and controversies in Conn’s syndrome. Nat Clin Pract Endocrinol Metab 3, 220-227, 2007.10.1038/ncpendmet043017315030]Open DOISearch in Google Scholar
[Schwartz GL, Turner ST. Screening for primary aldosteronism in essential hypertension: diagnostic accuracy of the ratio of plasma aldosterone concentration to plasma renin activity. Clin Chem 51, 386-394, 2005.10.1373/clinchem.2004.04178015681560]Search in Google Scholar
[Shen WT, Lim RC, Siperstein AE, Clark OH, Schecter WP, Hunt TK, Horn JK, Duh QY. Laparoscopic vs open adrenalectomy for the treatment of primary hyperaldosteronism. Arch Surg 134, 628-632, 1999.10.1001/archsurg.134.6.62810367872]Search in Google Scholar
[Sica DA. Pharmacokinetics and pharmacodynamics of mineralocorticoid blocking agents and their effects on potassium homeostasis. Heart Fail Rev 10, 23-29, 2005.10.1007/s10741-005-2345-115947888]Search in Google Scholar
[So A, Duffy DL, Gordon RD, Jeske YW, Lin-Su K, New MI, Stowasser M. Familial hyperaldosteronism type II is linked to the chromosome 7p22 region but also shows predicted heterogeneity. J Hypertens 23, 1477-1484, 2005.10.1097/01.hjh.0000174299.66369.2616003173]Search in Google Scholar
[Spyridonidis TJ, Apostolopoulos DJ. Is there a role for Nuclear Medicine in diagnosis and management of patients with primary aldosteronism? Hell J Nucl Med 16, 134-139, 2013.]Search in Google Scholar
[Steichen O, Lorthioir A, Zinzindohoue F, Plouin PF, Amar L. Outcomes of drug-based and surgical treatments for primary aldosteronism. Adv Chronic Kidney Dis 22, 196-203, 2015.10.1053/j.ackd.2014.10.00325908468]Search in Google Scholar
[Stowasser M, Gordon RD, Gunasekera TG, Cowley DC, Ward G, Archibald C, Smithers BM. High rate of detection of primary aldosteronism, including surgically treatable forms, after a “non-selective” screening of hypertensive patients. J Hypertens 21, 2149-2157, 2003.10.1097/00004872-200311000-0002514597859]Search in Google Scholar
[Stowasser M, Gordon RD. Primary aldosteronism--careful investigation is essential and rewarding. Mol Cell Endocrinol 217, 33-39, 2004.10.1016/j.mce.2003.10.00615134798]Search in Google Scholar
[Stowasser M, Sharman J, Leano R, Gordon RD, Ward G, Cowley D, Marwick TH. Evidence for abnormal left ventricular structure and function in normotensive individuals with familial hyperaldosteronism type I. J Clin Endocrinol Metab 90, 5070-5076, 2005.10.1210/jc.2005-068115941863]Search in Google Scholar
[Stowasser M, Ahmed A, Pimenta E, Taylor PJ, Gordon RD. Factors affecting the aldosterone/renin ratio. Horm Metab Res 44, 170-176, 2012.10.1055/s-0031-129546022147655]Search in Google Scholar
[Szolar DH, Korobkin M, Reittner P, Berghold A, Bauernhofer T, Trummer H, Schoellnast H, Preidler KW, Samonigg H. Adrenocortical carcinomas and adrenal pheochromocytomas: mass and enhancement loss evaluation at delayed contrast-enhanced CT. Radiology 234, 479-485, 2005.10.1148/radiol.234203187615671003]Search in Google Scholar
[TAIPAI Study Group, Wu VC, Chueh SC, Chang HW, Lin LY, Liu KL, Lin YH, Ho YL, Lin WC, Wang SM, Huang KH, Hung KY, Kao TW, Lin SL, Yen RF, Chen YM, Hsieh BS, Wu KD. Association of kidney function with residual hypertension after treatment of aldosterone-producing adenoma. Am J Kidney Dis 54, 665-673, 2009.10.1053/j.ajkd.2009.06.01419628318]Open DOISearch in Google Scholar
[Takeda M, Go H, Imai T, Nishiyama T, Morishita H. Laparoscopic adrenalectomy for primary aldosteronism: report of initial ten cases. Surgery 115, 621-625, 1994.]Search in Google Scholar
[Tang K, Li H, Xia D, Yu G, Guo X, Guan W, Xu H, Ye Z. Robot-assisted versus laparoscopic adrenalectomy: a systematic review and meta-analysis. J Laparoendosc Adv Surg Tech A 25, 187-195, 2015.10.1089/lap.2014.043125763475]Search in Google Scholar
[Thompson GB, Young WF Jr. Adrenal incidentaloma. Curr Opin Oncol 15, 84-90, 2003.10.1097/00001622-200301000-0001312490767]Open DOISearch in Google Scholar
[Tomaschitz A, Pilz S. Aldosterone to renin ratio--a reliable screening tool for primary aldosteronism? Horm Metab Res 42, 382-391, 2010.10.1055/s-0030-124832620225167]Open DOISearch in Google Scholar
[Utsumi T, Kawamura K, Imamoto T, Nagano H, Tanaka T, Kamiya N, Nihei N, Naya Y, Suzuki H, Ichikawa T. Preoperative masked renal damage in Japanese patients with primary aldosteronism: identification of predictors for chronic kidney disease manifested after adrenalectomy. Int J Urol 20, 685-691, 2013.10.1111/iju.1202923190329]Open DOISearch in Google Scholar
[Vaziri N. Dyslipidemia of chronic renal failure: the nature, mechanisms, and potential consequences. Am J Physiol Renal Physiol 290, F262-F272, 2006.10.1152/ajprenal.00099.200516403839]Search in Google Scholar
[Walz MK, Alesina PF, Wenger FA, Deligiannis A, Szuczik E, Petersenn S, Ommer A, Groeben H, Peitgen K, Janssen OE, Philipp T, Neumann HP, Schmid KW, Mann K. Posterior retroperitoneoscopic adrenalectomy--results of 560 procedures in 520 patients. Surgery 140, 943-950, 2006.10.1016/j.surg.2006.07.03917188142]Search in Google Scholar
[Weiner ID. Endocrine and hypertensive disorders of potassium regulation: primary aldosteronism. Semin Nephrol 33, 265-276, 2013.10.1016/j.semnephrol.2013.04.007374839023953804]Open DOISearch in Google Scholar
[White ML, Gauger PG, Doherty GM, Cho KJ, Thompson NW, Hammer GD, Miller BS. The role of radiologic studies in the evaluation and management of primary hyperaldosteronism. Surgery 144, 926-933, 2008.10.1016/j.surg.2008.07.02519040999]Search in Google Scholar
[Worth PJ, Kunio NR, Siegfried I, Sheppard BC, Gilbert EW. Characteristics predicting clinical improvement and cure following laparoscopic adrenalectomy for primary aldosteronism in a large cohort. Am J Surg 210, 702-709, 2015.10.1016/j.amjsurg.2015.05.03326323999]Search in Google Scholar
[Wu VC, Yang SY, Lin JW, Cheng BW, Kuo CC, Tsai CT, Chu TS, Huang KH, Wang SM, Lin YH, Chiang CK, Chang HW, Lin CY, Lin LY, Chiu JS, Hu FC, Chueh SC, Ho YL, Liu KL, Lin SL, Yen RF, Wu KD; TAIPAI Study Group. Kidney impairment in primary aldosteronism. Clin Chim Acta 412, 1319-1325, 2011.10.1016/j.cca.2011.02.01821345337]Search in Google Scholar
[Young WF Jr. Primary aldosteronism: management issues. Ann N Y Acad Sci 970, 61-76, 2002.10.1111/j.1749-6632.2002.tb04413.x12381542]Search in Google Scholar
[Young WF Jr. Minireview: primary aldosteronism--changing concepts in diagnosis and treatment. Endocrinology 144, 2208-2213, 2003a.10.1210/en.2003-027912746276]Search in Google Scholar
[Young WF Jr. Adrenalectomy for primary aldosteronism; authors’ reply. Ann Intern Med 138, 157-159, 2003b.10.7326/0003-4819-138-2-200301210-0002312529104]Search in Google Scholar
[Young WF, Stanson AW, Thompson GB, Grant CS, Farley DR, van Heerden JA. Role for adrenal venous sampling in primary aldosteronism. Surgery 136, 1227-1235, 2004.10.1016/j.surg.2004.06.05115657580]Search in Google Scholar
[Young WF Jr. Clinical practice. The incidentally discovered adrenal mass. N Engl J Med 356, 601-610, 2007.10.1056/NEJMcp06547017287480]Search in Google Scholar
[Young WF, Stanson AW. What are the keys to successful adrenal venous sampling (AVS) in patients with primary aldosteronism? Clin Endocrinol (Oxf) 70, 14-17, 2009.10.1111/j.1365-2265.2008.03450.x19128364]Search in Google Scholar
[Zarnegar R, Young WF Jr, Lee J, Sweet MP, Kebebew E, Farley DR, Thompson GB, Grant CS, Clark OH, Duh QY. The aldosteronoma resolution score: predicting complete resolution of hypertension after adrenalectomy for aldosteronoma. Ann Surg 247, 511-518, 2008.10.1097/SLA.0b013e318165c07518376197]Search in Google Scholar